| December 2007 |
| Renopharm has received a notice of allowance of its US patent application covering its lead compound Pet-8, for treating cardiovascular disorders and related medical conditions. |
| February 2007 |
| Renopharm Ltd. and Hemoteq AG to Develop Jointly a Drug-Eluting Stent Based on a New Novel Nitric Oxide donor technology (NO-DES) |
